Stock ARWR ARROWHEAD PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Estimates Revisions Arrowhead Pharmaceuticals, Inc.

Equities

ARWR

US04280A1007

Market Closed - Nasdaq
Other stock markets
 21:00:00 11/09/2024 BST 		5-day change 1st Jan Change
20.94 USD -2.47% Intraday chart for Arrowhead Pharmaceuticals, Inc. -12.68% -31.57%
09-10 Arrowhead Pharmaceuticals' Plozasiran Receives FDA Breakthrough Therapy Designation MT
09-10 Arrowhead Pharmaceuticals Gets FDA Breakthrough Designation for Plozasiran DJ

Turnover - Evolution of Analysts' Estimates

Earnings Per Share (EPS) - Evolution of Analysts' Estimates

EBIT - Evolution of Analysts' Estimates

Dividend / Share (DPS) - Evolution of Analysts' Estimates

Cash or Net Debt - Evolution of Analysts' Estimates

Add to a list
Add to a list

0 selected

To use this feature you must be a member
Log inSign up
 1m. EPS revision 1m. Revenue rev. 1y. EPS revision 1y. Revenue rev.
ARROWHEAD PHARMACEUTICALS, INC. Stock Arrowhead Pharmaceuticals, Inc.
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
ARGENX SE Stock argenx SE
BIONTECH SE Stock BioNTech SE
BEIGENE, LTD. Stock BeiGene, Ltd.
GENMAB A/S Stock Genmab A/S
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
VAXCYTE, INC. Stock Vaxcyte, Inc.
 - -
Average
Weighted average by Cap.
See all sector revisions

Turnover

Estimates Revisions:

Earnings Per Share (EPS)

Estimates Revisions:

EBIT

Estimates Revisions:

Dividend / Share (DPS)

Estimates Revisions:

Cash or Net Debt

Estimates Revisions:
  1. Stock Market
  2. Equities
  3. ARWR Stock
  4. Consensus Arrowhead Pharmaceuticals, Inc.
  5. Estimates Revisions
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW
United States

MarketScreener is also available in this country: United States.

Switch edition
Stay in the current country edition